Evidence map›Paper›PMID 37681768›Full record

ArticleInternational journal of environmental research and public health2023

Implementation of a Pharmacy Follow-Up Program for Dispensed Opioid Medications.

Elizabeth Skoy, Oliver Frenzel, Haley Pajunen, Heidi Eukel

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Persistent Opioid Use Following Major Orthopedic Surgery.Current pain and headache reports · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elizabeth SkoyDepartment of Pharmacy Practice, School of Pharmacy, North Dakota State University, Dept 2660, Fargo, ND 58108, USA.
Oliver FrenzelDepartment of Pharmacy Practice, School of Pharmacy, North Dakota State University, Dept 2660, Fargo, ND 58108, USA.
Haley PajunenDepartment of Pharmacy Practice, School of Pharmacy, North Dakota State University, Dept 2660, Fargo, ND 58108, USA.
Heidi EukelDepartment of Pharmacy Practice, School of Pharmacy, North Dakota State University, Dept 2660, Fargo, ND 58108, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere have been multiple reported pharmacy initiatives to reduce opioid misuse and accidental overdose to address our nation's public health crisis. To date, there has not been a description in the literature of a community pharmacy follow-up initiative for dispensed opioids.

methodsA follow-up program was designed and implemented in community pharmacies as part of a previously developed opioid overdose and misuse prevention program (ONE Program). Five to twelve days after the dispensing of an opioid, pharmacy technicians called the patient to follow up on opioid safety topics. Pharmacy technicians used a questionnaire to inquire about medication disposal plans, if the patient was taking the medication more than prescribed, medication side effects, and if the patient needed a pharmacist consultation. The results from that questionnaire were documented.

resultsDuring the first 18 months of the follow-up program, 1789 phone calls were completed. Of those contacted, 40% were still using their opioid medication, and over 10% were experiencing side effects which triggered a pharmacist consult. Patients were reminded of proper medication disposal methods, and most patients (78%) desired to dispose of unused medication at the pharmacy medication disposal box.

conclusionsFollow-up phone calls post-opioid medication dispensing were shown to add value to a previously established opioid misuse and accidental overdose prevention program and allowed for the fulfillment of the Pharmacist Patient Care Process.

Indexed as

Drug-Related Side Effects and Adverse ReactionsOpioid-Related DisordersPharmaciesPharmacyAnalgesics, OpioidFollow-Up StudiesHumansAnalgesics, Opioidfollow-upmedication disposalmedication safetyopioid medicationspharmacy technician

Identifiers

PMID37681768
PMCPMC10487139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.